TIMP1 and pachyonychia congenita: In particular, high levels of N30 glycosylation site occupation (TIMP-1 N30glycHI) was identified as an indicator of an increased mortality risk of PC patients, corroborating the impact of N30 glycosylation site occupation of TIMP-1 on cancer progression.